# Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies

> **NCT07346105** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Orca Biosystems, Inc.**

## Conditions studied

- Hematologic Malignancies
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
- Myelodysplastic Syndrome
- Mixed Phenotype Acute Leukemia

## Interventions

- **BIOLOGICAL:** Orca-T

## Key facts

- **NCT ID:** NCT07346105
- **Lead sponsor:** Orca Biosystems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07346105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07346105, "Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07346105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*